pentylenetetrazole has been researched along with Depression in 44 studies
Pentylenetetrazole: A pharmaceutical agent that displays activity as a central nervous system and respiratory stimulant. It is considered a non-competitive GAMMA-AMINOBUTYRIC ACID antagonist. Pentylenetetrazole has been used experimentally to study seizure phenomenon and to identify pharmaceuticals that may control seizure susceptibility.
pentetrazol : An organic heterobicyclic compound that is 1H-tetrazole in which the hydrogens at positions 1 and 5 are replaced by a pentane-1,5-diyl group. A central and respiratory stimulant, it was formerly used for the treatment of cough and other respiratory tract disorders, cardiovascular disorders including hypotension, and pruritis.
Depression: Depressive states usually of moderate intensity in contrast with MAJOR DEPRESSIVE DISORDER present in neurotic and psychotic disorders.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The effects of rapamycin on anxiety and depression caused by pentylenetetrazole (PTZ) in the rat and possible underlying mechanisms were evaluated." | 8.02 | Rapamycin attenuates depression and anxiety-like behaviors through modulation of the NLRP3 pathway in pentylenetetrazole-kindled male Wistar rats. ( Aghaie, F; Hosseini, A; Moradifar, F, 2021) |
| "We found that pterostilbene at a dose of 200 mg/kg considerably reduced seizure activity but did not influence the locomotor activity and depression- and anxiety-like behavior in the PTZ-kindled mice." | 8.02 | Anticonvulsant effect of pterostilbene and its influence on the anxiety- and depression-like behavior in the pentetrazol-kindled mice: behavioral, biochemical, and molecular studies. ( Nalepa, I; Nieoczym, D; Pieróg, M; Przejczowska-Pomierny, K; Socała, K; Szafarz, M; Wlaź, P; Wyska, E; Zelek-Molik, A, 2021) |
| "Epilepsy was induced in rats by injecting Pentylenetetrazole at 35 mg/kg every other day." | 7.96 | Glutamatergic pathway in depressive-like behavior associated with pentylenetetrazole rat model of epilepsy with history of prolonged febrile seizures. ( Alese, OO; Mabandla, MV; Mkhize, NV; Ngoupaye, GT; Rakgantsho, C; Zulu, S, 2020) |
| " This study was envisaged to evaluate the ameliorative effect of Curcumin on depression like behavior and cognitive impairment observed in pentylenetetrazole kindled animals." | 7.79 | Ameliorative effect of Curcumin on seizure severity, depression like behavior, learning and memory deficit in post-pentylenetetrazole-kindled mice. ( Choudhary, KM; Goel, RK; Mishra, A; Poroikov, VV, 2013) |
| " perforatum was compared with standard antidepressants using animal models of depression such as forced swim test (FST), yohimbine induced lethality test, pnetylenetetrazole (PTZ) induced convulsion and locomotor activity tests." | 7.79 | Behavioral profile of Hypericum perforatum (St. John's Wort) extract. A comparison with standard antidepressants in animal models of depression. ( Bukhari, IA; Dar, A, 2013) |
| "The intensity of convulsion was scored according to a seven-point scale ranging from stage 0-7." | 5.62 | Creatine attenuates seizure severity, anxiety and depressive-like behaviors in pentylenetetrazole kindled mice. ( Abiola, AL; Akhigbemen, AM; Chinazamoku, O; Igbe, I; Ogundepo, GE; Okwuofu, EO; Ozolua, RI, 2021) |
| "Epilepsy is fourth most common neurological disorders associated with depression and cognitive deficits." | 5.46 | Agmatine for combined treatment of epilepsy, depression and cognitive impairment in chronic epileptic animals. ( Bagga, N; Gawande, DY; Goel, RK; Kaur, A; Kaur, N; Singh, T, 2017) |
| "for 15 days." | 5.46 | Ferulic Acid Supplementation for Management of Depression in Epilepsy. ( Goel, RK; Kaur, T; Singh, T, 2017) |
| "Depression was evaluated in all experimental groups using the tail suspension and sucrose preference test on days 1, 5, 10 and 15, 2 h after pentylenetetrazole challenge." | 5.46 | Adjuvant quercetin therapy for combined treatment of epilepsy and comorbid depression. ( Goel, RK; Kaur, T; Singh, T, 2017) |
| "Pretreatment with spermine, considerably, reversed the PTZ induced alterations." | 5.46 | Protective effect of spermine against pentylenetetrazole kindling epilepsy induced comorbidities in mice. ( Kumar, M; Kumar, P, 2017) |
| "The effects of rapamycin on anxiety and depression caused by pentylenetetrazole (PTZ) in the rat and possible underlying mechanisms were evaluated." | 4.02 | Rapamycin attenuates depression and anxiety-like behaviors through modulation of the NLRP3 pathway in pentylenetetrazole-kindled male Wistar rats. ( Aghaie, F; Hosseini, A; Moradifar, F, 2021) |
| "We found that pterostilbene at a dose of 200 mg/kg considerably reduced seizure activity but did not influence the locomotor activity and depression- and anxiety-like behavior in the PTZ-kindled mice." | 4.02 | Anticonvulsant effect of pterostilbene and its influence on the anxiety- and depression-like behavior in the pentetrazol-kindled mice: behavioral, biochemical, and molecular studies. ( Nalepa, I; Nieoczym, D; Pieróg, M; Przejczowska-Pomierny, K; Socała, K; Szafarz, M; Wlaź, P; Wyska, E; Zelek-Molik, A, 2021) |
| " Epilepsy-associated comorbid depression was evaluated by tail suspension test, sucrose preference test, and plasma corticosterone levels, whereas epilepsy-associated memory deficit condition was assessed by step-through paradigm, Morris water maze, and nitrite levels." | 3.96 | Exploring the ameliorative role of α7 neuronal nicotinic acetylcholine receptor modulation in epilepsy and associated comorbidities in post-PTZ-kindled mice. ( Goel, RK; Kaur, S; Sharma, NK, 2020) |
| "Epilepsy was induced in rats by injecting Pentylenetetrazole at 35 mg/kg every other day." | 3.96 | Glutamatergic pathway in depressive-like behavior associated with pentylenetetrazole rat model of epilepsy with history of prolonged febrile seizures. ( Alese, OO; Mabandla, MV; Mkhize, NV; Ngoupaye, GT; Rakgantsho, C; Zulu, S, 2020) |
| "In view of well-evidenced antiepileptic effects of melatonin and few reports of anticonvulsant action of agomelatine, the present study investigated whether agomelatine protects against pentylenetetrazole (PTZ)-induced kindling in mice and kindling-associated oxidative stress, depression, and impairment of spatial memory." | 3.85 | Effects of agomelatine on pentylenetetrazole-induced kindling, kindling-associated oxidative stress, and behavioral despair in mice and modulation of its actions by luzindole and 1-(m-chlorophenyl) piperazine. ( Agarwal, NB; Azim, MS; Vohora, D, 2017) |
| " Owing to the major role of neuronal nitric oxide synthase (nNOS) in brain and ineffectiveness of antiepileptic drugs (AEDs) in restoring nitrosative stress, the present study was envisaged to evaluate the adjuvant nNOS inhibitor, 7-nitroindazole (7-NI) with valproic acid for combined treatment of epilepsy and associated depression." | 3.85 | Adjuvant neuronal nitric oxide synthase inhibition for combined treatment of epilepsy and comorbid depression. ( Goel, RK; Singh, T, 2017) |
| "The present study aimed to develop a neurochemistry-based single or adjuvant therapy approach for comprehensive management of epilepsy and associated depression employing pentylenetetrazole-kindled animals." | 3.83 | Evidence in support of using a neurochemistry approach to identify therapy for both epilepsy and associated depression. ( Goel, RK; Singh, T, 2016) |
| "Hence, this study was conducted to evaluate the effects of an active fraction extracted from the leaves of Crinum jagus against seizures, depression-like behaviour and oxidative stress in pentylenetetrazole (PTZ)-induced kindling in mice." | 3.83 | Anticonvulsant activity of an active fraction extracted from Crinum jagus L. (Amaryllidaceae), and its possible effects on fully kindled seizures, depression-like behaviour and oxidative stress in experimental rodent models. ( Dabole, B; De Waard, M; Menanga, JR; Taiwe, GS; Tchoya, TB, 2016) |
| " This study was envisaged to evaluate the ameliorative effect of Curcumin on depression like behavior and cognitive impairment observed in pentylenetetrazole kindled animals." | 3.79 | Ameliorative effect of Curcumin on seizure severity, depression like behavior, learning and memory deficit in post-pentylenetetrazole-kindled mice. ( Choudhary, KM; Goel, RK; Mishra, A; Poroikov, VV, 2013) |
| " perforatum was compared with standard antidepressants using animal models of depression such as forced swim test (FST), yohimbine induced lethality test, pnetylenetetrazole (PTZ) induced convulsion and locomotor activity tests." | 3.79 | Behavioral profile of Hypericum perforatum (St. John's Wort) extract. A comparison with standard antidepressants in animal models of depression. ( Bukhari, IA; Dar, A, 2013) |
| "The intensity of convulsion was scored according to a seven-point scale ranging from stage 0-7." | 1.62 | Creatine attenuates seizure severity, anxiety and depressive-like behaviors in pentylenetetrazole kindled mice. ( Abiola, AL; Akhigbemen, AM; Chinazamoku, O; Igbe, I; Ogundepo, GE; Okwuofu, EO; Ozolua, RI, 2021) |
| "Epilepsy is fourth most common neurological disorders associated with depression and cognitive deficits." | 1.46 | Agmatine for combined treatment of epilepsy, depression and cognitive impairment in chronic epileptic animals. ( Bagga, N; Gawande, DY; Goel, RK; Kaur, A; Kaur, N; Singh, T, 2017) |
| "for 15 days." | 1.46 | Ferulic Acid Supplementation for Management of Depression in Epilepsy. ( Goel, RK; Kaur, T; Singh, T, 2017) |
| "Depression was evaluated in all experimental groups using the tail suspension and sucrose preference test on days 1, 5, 10 and 15, 2 h after pentylenetetrazole challenge." | 1.46 | Adjuvant quercetin therapy for combined treatment of epilepsy and comorbid depression. ( Goel, RK; Kaur, T; Singh, T, 2017) |
| "Pretreatment with spermine, considerably, reversed the PTZ induced alterations." | 1.46 | Protective effect of spermine against pentylenetetrazole kindling epilepsy induced comorbidities in mice. ( Kumar, M; Kumar, P, 2017) |
| "Finally, we showed that kainate induced seizures and glycemia were not modified by spadin treatments." | 1.38 | Spadin as a new antidepressant: absence of TREK-1-related side effects. ( Borsotto, M; Coppola, T; Gandin, C; Heurteaux, C; Labbal, F; Mazella, J; Moha Ou Maati, H; Veyssiere, J; Widmann, C, 2012) |
| "(Passifloraceae) has been used for the treatment of epilepsy in several traditional systems of medicine." | 1.38 | Dual protective effect of Passiflora incarnata in epilepsy and associated post-ictal depression. ( Goel, RK; Singh, B; Singh, D, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 18 (40.91) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (2.27) | 29.6817 |
| 2010's | 16 (36.36) | 24.3611 |
| 2020's | 9 (20.45) | 2.80 |
| Authors | Studies |
|---|---|
| Wang, X | 1 |
| Xiao, A | 1 |
| Yang, Y | 1 |
| Zhao, Y | 1 |
| Wang, CC | 1 |
| Wang, Y | 1 |
| Han, J | 1 |
| Wang, Z | 1 |
| Wen, M | 1 |
| Sharma, NK | 1 |
| Kaur, S | 1 |
| Goel, RK | 12 |
| Alese, OO | 1 |
| Ngoupaye, GT | 1 |
| Rakgantsho, C | 1 |
| Mkhize, NV | 1 |
| Zulu, S | 1 |
| Mabandla, MV | 1 |
| Nesci, V | 1 |
| Russo, E | 1 |
| Arcidiacono, B | 1 |
| Citraro, R | 1 |
| Tallarico, M | 1 |
| Constanti, A | 1 |
| Brunetti, A | 1 |
| De Sarro, G | 1 |
| Leo, A | 1 |
| Polish, N | 1 |
| Nesterkina, M | 1 |
| Marintsova, N | 1 |
| Karkhut, A | 1 |
| Kravchenko, I | 1 |
| Novikov, V | 1 |
| Khairulin, A | 1 |
| Okwuofu, EO | 1 |
| Ogundepo, GE | 1 |
| Akhigbemen, AM | 1 |
| Abiola, AL | 1 |
| Ozolua, RI | 1 |
| Igbe, I | 1 |
| Chinazamoku, O | 1 |
| Aghaie, F | 1 |
| Moradifar, F | 1 |
| Hosseini, A | 1 |
| Nieoczym, D | 1 |
| Socała, K | 1 |
| Zelek-Molik, A | 1 |
| Pieróg, M | 1 |
| Przejczowska-Pomierny, K | 1 |
| Szafarz, M | 1 |
| Wyska, E | 1 |
| Nalepa, I | 1 |
| Wlaź, P | 1 |
| Singh, T | 6 |
| Mishra, A | 3 |
| Azim, MS | 1 |
| Agarwal, NB | 1 |
| Vohora, D | 1 |
| Bagga, N | 1 |
| Kaur, A | 1 |
| Kaur, N | 1 |
| Gawande, DY | 1 |
| Kaur, T | 2 |
| Choudhary, KM | 1 |
| Poroikov, VV | 1 |
| Bukhari, IA | 1 |
| Dar, A | 1 |
| Pahwa, P | 2 |
| Kaur, D | 1 |
| Taiwe, GS | 1 |
| Tchoya, TB | 1 |
| Menanga, JR | 1 |
| Dabole, B | 1 |
| De Waard, M | 1 |
| Kumar, M | 1 |
| Kumar, P | 1 |
| BOOKER, WM | 2 |
| FRENCH, DM | 2 |
| CARLSSON, A | 1 |
| THEANDER, G | 1 |
| Moha Ou Maati, H | 1 |
| Veyssiere, J | 1 |
| Labbal, F | 1 |
| Coppola, T | 1 |
| Gandin, C | 1 |
| Widmann, C | 1 |
| Mazella, J | 1 |
| Heurteaux, C | 1 |
| Borsotto, M | 1 |
| Takechi, K | 1 |
| Suemaru, K | 1 |
| Kawasaki, H | 1 |
| Araki, H | 1 |
| Singh, B | 1 |
| Singh, D | 2 |
| SCHERRER, P | 1 |
| LECLERC, J | 1 |
| LATOUCHE, M | 1 |
| LARSON, E | 1 |
| WYNN, MF | 1 |
| ADAMS, JP | 1 |
| TEBROCK, HE | 1 |
| YOUNG, W | 1 |
| O'DONNELL, W | 1 |
| KAUFMAN, M | 1 |
| VIDAL-TEIXIDOR, R | 1 |
| LISS, L | 1 |
| SOLZE, DA | 1 |
| FISCHER, R | 1 |
| KRAEMER, R | 1 |
| MELLINGHOFF, ML | 1 |
| MOLANO, PA | 1 |
| RHODES, C | 1 |
| Cao, BJ | 1 |
| Li, Y | 1 |
| Cole, JO | 1 |
| Stotsky, BA | 1 |
| Ferrini, R | 1 |
| Miragoli, G | 1 |
| Croce, G | 1 |
| Fink, M | 2 |
| Abrams, R | 1 |
| Neki, JS | 1 |
| Kishore, B | 1 |
| Winters, WD | 1 |
| Pelczarska, A | 1 |
2 reviews available for pentylenetetrazole and Depression
| Article | Year |
|---|---|
PTZ kindling model for epileptogenesis, refractory epilepsy, and associated comorbidities: relevance and reliability.
Topics: Animals; Anticonvulsants; Cognitive Dysfunction; Depression; Disease Models, Animal; Drug Resistance | 2021 |
CNS effects of convulsive therapy: significance for a theory of depressive psychosis.
Topics: Alpha Rhythm; Amobarbital; Antidepressive Agents; Bipolar Disorder; Brain; Depression; Electroconvul | 1972 |
42 other studies available for pentylenetetrazole and Depression
| Article | Year |
|---|---|
DHA and EPA Prevent Seizure and Depression-Like Behavior by Inhibiting Ferroptosis and Neuroinflammation via Different Mode-of-Actions in a Pentylenetetrazole-Induced Kindling Model in Mice.
Topics: Animals; Depression; Docosahexaenoic Acids; Eicosapentaenoic Acid; Ferroptosis; Mice; Neuroinflammat | 2022 |
Exploring the ameliorative role of α7 neuronal nicotinic acetylcholine receptor modulation in epilepsy and associated comorbidities in post-PTZ-kindled mice.
Topics: alpha7 Nicotinic Acetylcholine Receptor; Animals; Anticonvulsants; Corticosterone; Depression; Dose- | 2020 |
Glutamatergic pathway in depressive-like behavior associated with pentylenetetrazole rat model of epilepsy with history of prolonged febrile seizures.
Topics: Amygdala; Animals; Brain-Derived Neurotrophic Factor; Depression; Epilepsy; Excitatory Amino Acid Tr | 2020 |
Metabolic Alterations Predispose to Seizure Development in High-Fat Diet-Treated Mice: the Role of Metformin.
Topics: Animals; Anxiety; Avoidance Learning; Behavior, Animal; Blood Glucose; Body Composition; Depression; | 2020 |
Synthesis and Evaluation on Anticonvulsant and Antidepressant Activities of Naphthoquinone Derivatives Containing Pyrazole and Pyrimidine Fragments.
Topics: Animals; Animals, Outbred Strains; Anticonvulsants; Antidepressive Agents; Depression; Male; Mice; N | 2020 |
Creatine attenuates seizure severity, anxiety and depressive-like behaviors in pentylenetetrazole kindled mice.
Topics: Animals; Anxiety; Convulsants; Creatine; Depression; Dose-Response Relationship, Drug; Glutathione; | 2021 |
Rapamycin attenuates depression and anxiety-like behaviors through modulation of the NLRP3 pathway in pentylenetetrazole-kindled male Wistar rats.
Topics: Animals; Anxiety; Depression; Kindling, Neurologic; Male; NLR Family, Pyrin Domain-Containing 3 Prot | 2021 |
Anticonvulsant effect of pterostilbene and its influence on the anxiety- and depression-like behavior in the pentetrazol-kindled mice: behavioral, biochemical, and molecular studies.
Topics: Animals; Anticonvulsants; Anxiety; Chromatography, Liquid; Depression; Kindling, Neurologic; Mice; P | 2021 |
Effects of agomelatine on pentylenetetrazole-induced kindling, kindling-associated oxidative stress, and behavioral despair in mice and modulation of its actions by luzindole and 1-(m-chlorophenyl) piperazine.
Topics: Acetamides; Animals; Anticonvulsants; Antioxidants; Depression; Drug Therapy, Combination; Epilepsy; | 2017 |
Agmatine for combined treatment of epilepsy, depression and cognitive impairment in chronic epileptic animals.
Topics: Agmatine; Animals; Cognitive Dysfunction; Depression; Epilepsy; Male; Mice; Pentylenetetrazole | 2017 |
Ferulic Acid Supplementation for Management of Depression in Epilepsy.
Topics: Animals; Anticonvulsants; Brain; Coumaric Acids; Depression; Depressive Disorder; Disease Models, An | 2017 |
Ameliorative effect of Curcumin on seizure severity, depression like behavior, learning and memory deficit in post-pentylenetetrazole-kindled mice.
Topics: Acetylcholinesterase; Animals; Anticonvulsants; Behavior, Animal; Brain; Convulsants; Curcumin; Depr | 2013 |
Behavioral profile of Hypericum perforatum (St. John's Wort) extract. A comparison with standard antidepressants in animal models of depression.
Topics: Animals; Antidepressive Agents; Depression; Disease Models, Animal; Hypericum; Male; Mice; Motor Act | 2013 |
Ameliorative effect of Asparagus racemosus root extract against pentylenetetrazol-induced kindling and associated depression and memory deficit.
Topics: Animals; Anticonvulsants; Asparagus Plant; Depression; Dose-Response Relationship, Drug; Epilepsy; K | 2016 |
Protective Effect of Nerolidol Against Pentylenetetrazol-Induced Kindling, Oxidative Stress and Associated Behavioral Comorbidities in Mice.
Topics: Animals; Behavior, Animal; Comorbidity; Depression; Glutathione; Kindling, Neurologic; Male; Memory | 2016 |
Evidence in support of using a neurochemistry approach to identify therapy for both epilepsy and associated depression.
Topics: Animals; Anticonvulsants; Brain; Depression; Depressive Disorder; Disease Models, Animal; Dopamine; | 2016 |
Anticonvulsant activity of an active fraction extracted from Crinum jagus L. (Amaryllidaceae), and its possible effects on fully kindled seizures, depression-like behaviour and oxidative stress in experimental rodent models.
Topics: Animals; Anticonvulsants; Crinum; Depression; Disease Models, Animal; Kindling, Neurologic; Male; Mi | 2016 |
Adjuvant neuronal nitric oxide synthase inhibition for combined treatment of epilepsy and comorbid depression.
Topics: Animals; Anticonvulsants; Chemotherapy, Adjuvant; Depression; Dose-Response Relationship, Drug; Enzy | 2017 |
Adjuvant quercetin therapy for combined treatment of epilepsy and comorbid depression.
Topics: Animals; Anticonvulsants; Behavior, Animal; Brain; Combined Modality Therapy; Convulsants; Depressio | 2017 |
Protective effect of spermine against pentylenetetrazole kindling epilepsy induced comorbidities in mice.
Topics: Animals; Arginine; Avoidance Learning; Brain; Catecholamines; Comorbidity; Depression; Epilepsy; gam | 2017 |
Re-evaluation of the effectiveness of metrazol as an analeptic agent in barbiturate depression.
Topics: Barbital; Barbiturates; Central Nervous System Stimulants; Depression; Depressive Disorder; Pentylen | 1948 |
On the stimulant and depressant effects of pentamethylenetetrazol in sodium diethyl barbiturate depression.
Topics: Barbital; Barbiturates; Central Nervous System Stimulants; Depression; Depressive Disorder; Humans; | 1946 |
Spadin as a new antidepressant: absence of TREK-1-related side effects.
Topics: Animals; Antidepressive Agents; Biophysical Phenomena; Blood Glucose; Brain Infarction; CD8 Antigens | 2012 |
Regulatory role of the dopamine and norepinephrine transporters in pentylenetetrazol-kindled mice: association with effect of antidepressants.
Topics: Adrenergic Uptake Inhibitors; Animals; Antidepressive Agents; Atomoxetine Hydrochloride; Bupropion; | 2011 |
Dual protective effect of Passiflora incarnata in epilepsy and associated post-ictal depression.
Topics: Animals; Anticonvulsants; Antidepressive Agents; Behavior, Animal; Brain; Convulsants; Depression; E | 2012 |
Effect of saponin fraction from Ficus religiosa on memory deficit, and behavioral and biochemical impairments in pentylenetetrazol kindled mice.
Topics: Analysis of Variance; Animals; Avoidance Learning; Brain; Chromatography, High Pressure Liquid; Depr | 2013 |
[Spectacular cure by cardiazol therapy of an atypical melancholia apparently incurable].
Topics: Convulsive Therapy; Depression; Depressive Disorder; Humans; Pentylenetetrazole | 1953 |
Studies of pentobarbital depression.
Topics: Barbiturates; Depression; Depressive Disorder; Humans; Pentobarbital; Pentylenetetrazole; Poisoning; | 1954 |
A combined psychic and somatic stimulant in the management of industrial fatigue and mild depression.
Topics: Amphetamine; Amphetamines; Central Nervous System Stimulants; Depression; Fatigue; Humans; Occupatio | 1959 |
[On the treatment of depressive states in aged persons].
Topics: Dementia; Depression; Depressive Disorder; Humans; Inositol; Pentylenetetrazole; Psychotic Disorders | 1963 |
THE HISTOMORPHOLOGY OF EXPERIMENTAL EXCITATION.
Topics: Acridines; Coloring Agents; Depression; Depressive Disorder; Hippocampus; Histology; Lysergic Acid D | 1964 |
[Observations on the therapeutic use of sub-shock doses of cardiazol].
Topics: Convulsive Therapy; Depression; Depressive Disorder; Pentylenetetrazole; Shock | 1950 |
[Recent experiences with sub-shock cardiazol therapy].
Topics: Aged; Convulsive Therapy; Depression; Depressive Disorder; Humans; Pentylenetetrazole | 1950 |
Re-evaluation of the effectiveness of pentamethylenetetrazol (metrazol) as an analeptic agent during thiopental depression.
Topics: Central Nervous System Stimulants; Depression; Depressive Disorder; Humans; Pentylenetetrazole; Thio | 1950 |
Reduced anxiety-- and depression-like behaviors in Emx1 homozygous mutant mice.
Topics: Acoustic Stimulation; Animals; Anxiety; Convulsants; Depression; Exploratory Behavior; Female; Genet | 2002 |
Improving psychiatric drug therapy. A matter of dosage and choice.
Topics: Adrenal Cortex Hormones; Adult; Aged; Anticoagulants; Antidepressive Agents; Antiparkinson Agents; B | 1974 |
Pharmacological actions of 1-(o-methoxyphenoxy)3-isopropylamino-2-propanol hydrochloride (S-D-1601), a new beta-blocking agent.
Topics: Adrenergic beta-Antagonists; Amphetamine; Anesthetics, Local; Animals; Anti-Arrhythmia Agents; Antic | 1970 |
Answers to questions frequently asked about ECT.
Topics: Age Factors; Anesthesia, Intravenous; Brain Damage, Chronic; Brain Neoplasms; Depression; Electrocon | 1972 |
Letters to the editor: Drug dosage in ECT.
Topics: Depression; Diazepam; Electroconvulsive Therapy; Humans; Injections, Intravenous; Methohexital; Pent | 1973 |
Narcostimulation in depressive states.
Topics: Accidents; Amnesia; Anesthesia; Apnea; Central Nervous System; Convulsive Therapy; Depression; Elect | 1968 |
Epilepsy or anesthesia with ketamine.
Topics: Anesthesia; Anesthetics; Animals; Cataplexy; Cats; Central Nervous System; Cyclohexanes; Depression; | 1972 |
On the central action of some oxoindole compounds.
Topics: Absorption; Amphetamine; Animals; Blood Pressure; Central Nervous System; Depression; Drug Antagonis | 1969 |